BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Business

  4DMT Reports First Quarter 2024 Financial Results and Operational Highlights

  4D Molecular Therapeutics, a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market diseases, reported first quarter 2024 financial results and provided operational highlights.

  May 9, 2024

   · 

  11 min read
• Biotech Beach

  Anaptys to Receive $50 Million in a Capped Non-Recourse Monetization from Amended Agreement with Sagard in Exchange for Additional Jemperli Royalties

  AnaptysBio, Inc., a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, announced the execution of an amended agreement with Sagard Healthcare for additional Anaptys Jemperli royalties.

  May 9, 2024

   · 

  7 min read
• Business

  Oncternal Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results

  Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, provided a business update and reported first quarter 2024 financial results.

  May 9, 2024

   · 

  8 min read
• Genetown

  Rhythm Pharmaceuticals Announces New Employment Inducement Grants - May 09, 2024

  Rhythm Pharmaceuticals, Inc. announced that on May 6, 2024, the Compensation Committee of Rhythm’s board of directors granted inducement restricted stock units, or RSUs, covering an aggregate of 15,150 shares of its common stock to seven new employees.

  May 9, 2024

   · 

  7 min read
• Business

  Acutus Medical Reports First Quarter 2024 Financial Results

  Acutus Medical, Inc. reported results for the first quarter of 2024.

  May 9, 2024

   · 

  8 min read
• Business

  Ginkgo Bioworks Reports First Quarter 2024 Financial Results

  Ginkgo Bioworks Holdings, Inc., which is building the leading platform for cell programming and biosecurity, announced its results for the first quarter ended March 31, 2024.

  May 9, 2024

   · 

  19 min read
• Business

  SenesTech Announces First Quarter 2024 Financial Results

  SenesTech, Inc., the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products announced financial results for the first quarter of 2024.

  May 9, 2024

   · 

  9 min read
• Business

  BioLife Solutions Reports First Quarter 2024 Financial Results

  BioLife Solutions, Inc. announced financial results for the three months ended March 31, 2024 and affirmed its revenue guidance for 2024.

  May 9, 2024

   · 

  17 min read
• Business

  Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights

  Tyra Biosciences, Inc. reported financial results for the quarter ended March 31, 2024, and highlighted recent corporate progress.

  May 9, 2024

   · 

  11 min read
• Business

  Regulus Therapeutics Reports First Quarter 2024 Financial Results and Recent Updates

  Regulus Therapeutics Inc., a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, reported financial results for the first quarter ended March 31, 2024, and provided a corporate update.

  May 9, 2024

   · 

  8 min read